State Street
SANA icon

State Street’s Sana Biotechnology SANA Stock Holding History

State Street’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.3M Buy
10,538,086
+2,483,245
+31% +$9.78M ﹤0.01% 2003
2025
Q4 		$32.8M Buy
8,054,841
+1,374,300
+21% +$6.15M ﹤0.01% 1987
2025
Q3 		$23.7M Buy
6,680,541
+3,820,417
+134% +$13.8M ﹤0.01% 2142
2025
Q2 		$7.81M Sell
2,860,124
-2,632,409
-48% -$5.43M ﹤0.01% 2736
2025
Q1 		$9.23M Sell
5,492,533
-1,217,128
-18% -$3.4M ﹤0.01% 2572
2024
Q4 		$10.9M Buy
6,709,661
+82,341
+1% +$246K ﹤0.01% 2579
2024
Q3 		$27.6M Buy
6,627,320
+269,274
+4% +$1.41M ﹤0.01% 2033
2024
Q2 		$34.7M Sell
6,358,046
-12,119
-0.2% -$96.6K ﹤0.01% 1844
2024
Q1 		$63.7M Buy
6,370,165
+461,478
+8% +$3.46M ﹤0.01% 1595
2023
Q4 		$24.1M Buy
5,908,687
+1,300,194
+28% +$4.79M ﹤0.01% 2113
2023
Q3 		$17.8M Sell
4,608,493
-229,310
-5% -$1.23M ﹤0.01% 2235
2023
Q2 		$28.8M Sell
4,837,803
-855,577
-15% -$4.93M ﹤0.01% 2006
2023
Q1 		$18.6M Sell
5,693,380
-1,095,371
-16% -$4.38M ﹤0.01% 2274
2022
Q4 		$26.8M Buy
6,788,751
+240,669
+4% +$1.18M ﹤0.01% 2035
2022
Q3 		$39.3M Sell
6,548,082
-2,046,331
-24% -$14.8M ﹤0.01% 1772
2022
Q2 		$55.3M Buy
8,594,413
+1,443,483
+20% +$9.2M ﹤0.01% 1574
2022
Q1 		$59.1M Buy
7,150,930
+3,614,591
+102% +$29.2M ﹤0.01% 1654
2021
Q4 		$54.7M Buy
3,536,339
+879,829
+33% +$17M ﹤0.01% 1743
2021
Q3 		$59.8M Buy
2,656,510
+680,068
+34% +$14.3M ﹤0.01% 1675
2021
Q2 		$38.9M Buy
1,976,442
+1,765,281
+836% +$40M ﹤0.01% 2035
2021
Q1 		$7.07M Buy
+211,161
New +$6.88M ﹤0.01% 2897

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street's SANA Position: Q1 2026 in Review

State Street increased its Sana Biotechnology (SANA) stake by 31% in Q1 2026, buying an estimated $9.78M and bringing the position to 10,538,086 shares worth $30.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

State Street first reported a position in SANA in Q1 2021 and has held it in 21 quarters since. The position peaked at $63.7M in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • State Street held 10,538,086 shares of Sana Biotechnology worth $30.3M as of Q1 2026.
  • State Street bought 2,483,245 Sana Biotechnology shares in Q1 2026, an estimated $9.78M.
  • Sana Biotechnology made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2003 holding.
  • State Street first reported a position in Sana Biotechnology in Q1 2021 and has held it in 21 quarters since.
  • State Street's Sana Biotechnology position peaked at $63.7M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.